PIN23 Economic Evaluation of Protease Inhibitors for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Kazakhstan

Almadiyeva, A.; Ibrayev, S.; Turgambayeva, A.; Nurgozhin, T.

NUR Home
→
02.National Laboratory Astana
→
Center for Life Sciences
→
Laboratory of Epidemiology and Public Health
→
View Item

dc.contributor.author	Almadiyeva, A.
dc.contributor.author	Ibrayev, S.
dc.contributor.author	Turgambayeva, A.
dc.contributor.author	Nurgozhin, T.
dc.creator	A., Almadiyeva
dc.date.accessioned	2017-12-14T05:51:58Z
dc.date.available	2017-12-14T05:51:58Z
dc.date.issued	2016-11-01
dc.identifier	DOI:10.1016/j.jval.2016.08.144
dc.identifier.citation	A Almadiyeva, S Ibrayev, A Turgambayeva, T Nurgozhin, PIN23 - Economic Evaluation of Protease Inhibitors for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Kazakhstan, In Value in Health, Volume 19, Issue 7, 2016, Pages A911-A912
dc.identifier.issn	10983015
dc.identifier.uri	https://www.sciencedirect.com/science/article/pii/S1098301516307240
dc.identifier.uri	http://nur.nu.edu.kz/handle/123456789/2892
dc.relation.ispartof	Value in Health
dc.title	PIN23 Economic Evaluation of Protease Inhibitors for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Kazakhstan
dc.type	Article
dc.rights.license	Copyright © 2016 Published by Elsevier Inc.
dcterms.provenance	Value in Health
elsevier.identifier.doi	10.1016/j.jval.2016.08.144
elsevier.identifier.eid	1-s2.0-S1098301516307240
elsevier.identifier.pii	S1098-3015(16)30724-0
elsevier.volume	19
elsevier.issue.identifier	7
elsevier.coverdate	2016-11-01
elsevier.coverdisplaydate	November 2016
elsevier.startingpage	A911
elsevier.endingpage	A912
elsevier.openaccess	1
elsevier.openaccessarticle	true
elsevier.openarchivearticle	true
elsevier.openaccessuserlicense	http://www.elsevier.com/open-access/userlicense/1.0/
elsevier.aggregationtype	Journal